Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

38.02
+0.51001.36%
Post-market: 38.020.00000.00%16:42 EDT
Volume:1.45M
Turnover:56.35M
Market Cap:2.66B
PE:-12.70
High:40.60
Open:38.13
Low:37.47
Close:37.51
52wk High:43.25
52wk Low:20.65
Shares:69.86M
Float Shares:43.70M
Volume Ratio:0.73
T/O Rate:3.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9943
EPS(LYR):-3.4871
ROE:-70.46%
ROA:-42.32%
PB:7.62
PE(LYR):-10.90

Loading ...

Stock Track | Pharvaris N.V. Soars 5.09% Intraday on Bullish Analyst Ratings

Stock Track
·
May 14

Pharvaris Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 13

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (STXS)

TIPRANKS
·
May 13

RBC Capital Reaffirms Their Buy Rating on Pharvaris (PHVS)

TIPRANKS
·
May 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Pharvaris price target lowered to $74 from $75 at Citizens

TIPRANKS
·
May 13

Pharvaris Q1 EPS $(0.69) Beats $(0.77) Estimate

Benzinga Earnings
·
May 13

Pharvaris Q1 Loss Narrows

MT Newswires Live
·
May 13

Earnings Flash (PHVS) Pharvaris Posts Q1 Per Share Loss 0.59 Euro, vs. FactSet Est of 0.71 Euro Loss

MT Newswires Live
·
May 13

Switzerland's Pharvaris Q1 loss per share narrows

Reuters
·
May 13

Pharvaris Q1 FY26 loss narrows to €39.2 million

Reuters
·
May 13

Pharvaris N.v. Q1 EPS EUR -0.59

THOMSON REUTERS
·
May 13

Press Release: Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 13

Pharvaris Raises $124 Million in May Equity Offering to Fund Late-Stage Programs and U.S. Commercial Build-Out

TIPRANKS
·
May 12

Pharvaris closes follow-on offering, raises $132.3 million gross proceeds

Reuters
·
May 12

Press Release: Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
May 12

Pharvaris price target raised to $31 from $30 at BofA

TIPRANKS
·
May 10

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), BioAge Labs, Inc. (BIOA) and Pharvaris (PHVS)

TIPRANKS
·
May 10

BRIEF-Pharvaris Announces Pricing Of $115 Million Underwritten Offering Of Ordinary Shares

Reuters
·
May 08

Pharvaris prices $115 million follow-on offering at $29.68 per share

Reuters
·
May 08